Victory Capital Management Inc Aridis Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$5.24 - $8.97 $5,418 - $9,274	-1,034 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$4.34 - $8.3 $104 - $199	-24 Reduced 2.27%	1,034 $6,000
Q4 2019 Feb 04, 2020	BUY	$4.16 - $7.1 $515 - $880	124 Added 13.28%	1,058 $7,000
Q3 2019 Nov 12, 2019	BUY	$6.57 - $12.2 $6,136 - $11,394	934 New	934 $6,000

50.2K

Ticker ARDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,701,600
Description
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.